Jeil Pharmaceutical is a OTC, Pharmaceutical company, Manufacturer/Innovator, CMO/CDMO, Generics/Biosimilars Manufacturer company operating in the pharmaceutical industry.
Jeil Pharmaceutical Co., Ltd. founded in 1959 has developed and supplied superior pharmaceutical products to promote the happiness and health of mankind and has contributed to the growth and development of the pharmaceutical industry in Korea. Jeil’s factory received KGMP approval in 1987, and produces tablets, capsules, injections, finished pharmaceutical products including patches, and Active Pharmaceutical Ingredients(APIs) such as anti-biotic ingredients, etc.
Company type
OTC, Pharmaceutical company, Manufacturer/Innovator, CMO/CDMO, Generics/Biosimilars Manufacturer
Products and services
Custom Manufacturing, Finished Dosage Forms, APIs (Active Pharmaceutical Ingredients)
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Jeil Pharmaceutical on LinkedIn
Address
Jeil Pharmaceutical, #745-5, Banpo-dong, Seocho-gu,, Seoul, Korea, Republic of, 137-849
Stay ahead of trends and best practices
